Treatment of cancer pain with systematically administered opioids;Behandeling van pijn bij kanker met systemisch toegediende opioïden

Nederlands Tijdschrift voor Geneeskunde

Volumn 145, Issue 20, 2001, Pages 950-954

  Enting, R H ^a   Van Der Rijt, C C D ^a   Wilms, E B ^a   Lieverse, P J ^a   De Wit, R ^a   Sillevis Smitt, P A E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ARTICLE; CANCER PAIN; CONTROLLED RELEASE FORMULATION; DOSE CALCULATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG INFUSION; DRUG POTENCY; HUMAN; PRACTICE GUIDELINE; SELF REPORT; SIDE EFFECT; SPINAL ANESTHESIA; WORLD HEALTH ORGANIZATION;

ANALGESICS, OPIOID; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFUSION PUMPS; METHADONE; MORPHINE; NEOPLASMS; NETHERLANDS; OXYCODONE; PAIN; PALLIATIVE CARE; PRACTICE GUIDELINES; WORLD HEALTH ORGANIZATION;

EID: 0035912501     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Pain and its treatment in outpatients with metastatic cancer
2. Validation of World Health Organization guidelines for cancer pain relief: A 10-year prospective study
3. Continue epidurale infusie van opiaten; een nieuwe vorm van pijnbestrijding bij patiënten in het terminale stadium van ziekte
4. Continue intrathecale pijnbestrijding bij terminale kankerpatiënten in de transmurale zorg
5. Patient-related barriers to management of cancer pain
6. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group
7. Empirical comparison of commonly used measures to evaluate pain treatment in cancer patients with chronic pain
8. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function
9. Application of the American Pain Society quality assurance standards
10. A pain education program for chronic cancer pain patients: Follow-up results from a randomized controlled trial
11. Breakthrough pain: Characteristics and impact in patients with cancer pain
12. Pharmacologic treatment of cancer pain
13. Opioid rotation for cancer pain: Rationale and clinical aspects
14. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life
15. Controlled release morphine tablets: A double-blind trial in patients with advanced cancer
16. Oral transmucosal fentanyl citrate: Randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients
17. Management of cancer pain
18. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: A controlled dose titration study
19. Treatment of severe cancer pain by low-dose continuous subcutaneous morphine
20. Patient-controlled analgesia for chronic cancer pain in the ambulatory setting: A report of 117 patients
21. A comparison of subcutaneous morphine and fentanyl in hospice cancer patients
22. Continuous subcutaneous infusion of morphine vs. hydromorphone: A controlled trial
23. Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management
24. Opioid substitution 10 reduce adverse effects in cancer pain management
25. Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio?
26. Outcome and complications of epidural analgesia in patients with chronic cancer pain
27. Epidural and subcutaneous morphine in the management of cancer pain: A double-blind cross-over study
28. Complications of intrathecal opioids and bupivacaine in the treatment of 'refractory' cancer pain
29. Sedatie in de laatste levensfase
30. Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: A randomized, double-blind, parallel-group study
31. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled- release morphine in patients with cancer pain